Showing 2191-2200 of 9130 results for "".
Gettin' Social With It
https://practicaldermatology.com/topics/practice-management/gettin-social-with-it/19728/An online presence is important, maybe even essential. But there are right and wrong ways to approach social media marketing. Joel Cohen, MD talks to Risa Luksa about the practices and pitfalls of social media.Surgery Not Required?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/surgery-not-required/19723/Patients increasingly want non-surgical options for skin tightening. Fortunately, a plethora of highly effective options exist, from ultrasound to radiofrequency, according to Mitchel Goldman, MD.The Science Driving Topicals Into the Future
https://practicaldermatology.com/topics/psoriasis/the-science-driving-topicals-into-the-future/19721/On the therapeutic front, one topic Neal Bhatia, MD is paying particularly close attention to is recent advances in vehicle science, which offer novel and intriguing strategies to improve delivery of topical applications to and through the skin.What Are You Looking Forward to at SDDS?
https://practicaldermatology.com/topics/practice-management/what-are-you-looking-forward-to-at-sdds/19717/Sarah Lonowski, MD, MBA, Division of Dermatology, University of California Los Angeles, Los Angeles talks about what she hopes to learn at the inaugural SDDS in May. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterContinental San Diego: sddeDermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years ofDermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopAsk an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Food and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/food-and-atopic-dermatitis/19644/Many patients believe certain foods can exacerbate AD. Peter Lio, MD discusses the potential link.Tips for Dealing with Difficult Patients
https://practicaldermatology.com/topics/practice-management/tips-for-dealing-with-difficult-patients/19642/Every physician has to deal with a difficult patient from time to time. Kanade Shinkai, MD offers tips to improve patient visits.The Risk of Violence Against Physicians
https://practicaldermatology.com/topics/practice-management/the-risk-of-violence-against-physicians/19641/Violence against healthcare workers is a real and growing risk. Kathleen J. Hectorne, MD outlines the problem and ways to de-escalate an encounter.